Primary Microcephaly Gene MCPH1 Shows Signatures of Tumor Suppressors and Is Regulated by miR-27a in Oral Squamous Cell Carcinoma

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Venkatesh, Thejaswini ^a   Nagashri, Mathighatta Nagaraj ^a   Swamy, Shivananda S ^b   Mohiyuddin, S M Azeem ^c   Gopinath, Kodaganur S ^b   Kumar, Arun ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b Bangalore Institute of Oncology   (India)

^c SRI DEVARAJ URS MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MICROCEPHALIN 1; MICRORNA; MICRORNA 27A; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; MCPH1 PROTEIN, HUMAN; MIRN27 MICRORNA, HUMAN; NERVE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER INVASION; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCUS; GENE OVEREXPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MCPH1 GENE; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PROMOTER REGION; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; GENETICS; HELA CELL LINE; MOUTH TUMOR; MUTATION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HELA CELLS; HUMANS; LOSS OF HETEROZYGOSITY; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MOUTH NEOPLASMS; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NERVE TISSUE PROTEINS;

EID: 84874609790     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054643     Document Type: Article

References (55)

1. Lin SY, Elledge SJ, (2003) Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113: 881-889.
2. Jackson AP, Eastwood H, Bell SM, Adu J, Toomes C, et al. (2002) Identification of microcephalin, a protein implicated in determining the size of the human brain. Am J Hum Genet 71: 136-142.
3. Trimborn M, Bell SM, Felix C, Rashid Y, Jafri H, et al. (2004) Mutations in microcephalin cause aberrant regulation of chromosome condensation. Am J Hum Genet 75: 261-266.
4. Rai R, Dai H, Multani AS, Li K, Chin K, et al. (2006) BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer. Cancer Cell 10: 145-157.
5. Peng G, Lin SY, (2009) BRIT1/MCPH1 is a multifunctional DNA damage responsive protein mediating DNA repair-associated chromatin remodeling. Cell Cycle 8: 3071-3072.
6. Wood JL, Liang Y, Li K, Chen J, (2008) Microcephalin/MCPH1 associates with the condensin II complex to function in homologous recombination repair. J Biol Chem 283: 29586-29592.
7. Yang SZ, Lin FT, Lin WC, (2008) MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosis. EMBO Rep 9: 907-915.
8. Rai R, Phadnis A, Haralkar S, Badwe RA, Dai H, et al. (2008) Differential regulation of centrosome integrity by DNA damage response proteins. Cell Cycle 7: 2225-2233.
9. Tibelius A, Marhold J, Zentgraf H, Heilig CE, Neitzel H, et al. (2009) Microcephalin and pericentrin regulate mitotic entry via centrosome-associated Chk1. J Cell Biol 185: 1149-1157.
10. Brown JA, Bourke E, Liptrot C, Dockery P, Morrison CG, (2010) MCPH1/BRIT1 limits ionizing radiation-induced centrosome amplification. Oncogene 29: 5537-5544.
11. Liang Y, Gao H, Lin SY, Peng G, Huang X, et al. (2010) BRIT1/MCPH1 is essential for mitotic and meiotic recombination DNA repair and maintaining genomic stability in mice. PLoS Genet 6: e1000826.
12. Trimborn M, Ghani M, Walther DJ, Dopatka M, Dutrannoy V, et al. (2010) Establishment of a mouse model with misregulated chromosome condensation due to defective Mcph1 function. PLoS ONE 5: e9242.
13. Gruber R, Zhou Z, Sukchev M, Joerss T, Frappart PO, et al. (2011) MCPH1 regulates the neuroprogenitor division mode by coupling the centrosomal cycle with mitotic entry through the Chk1-Cdc25 pathway. Nat Cell Biol 13: 1325-1334.
14. Wu CL, Roz L, Sloan P, Read AP, Holland S, et al. (1997) Deletion mapping defines three discrete areas of allelic imbalance on chromosome arm 8p in oral and oropharyngeal squamous cell carcinomas. Genes Chromosomes Cancer 20: 347-353.
15. Lu T, Hano H, Meng C, Nagatsuma K, Chiba S, et al. (2007) Frequent loss of heterozygosity in two distinct regions, 8p23.1 and 8p22, in hepatocellular carcinoma. World J Gastroenterol 13: 1090-1097.
16. Bilbao C, Ramirez R, Rodriguez G, Falcon O, Leon L, et al. (2010) Double strand break repair components are frequent targets of microsatellite instability in endometrial cancer. Eur J Cancer 46: 2821-2827.
17. Richardson J, Shaaban AM, Kamal M, Alisary R, Walker C, et al. (2011) Microcephalin is a new novel prognostic indicator in breast cancer associated with BRCA1 inactivation. Breast Cancer Res Treat 127: 639-648.
18. Sobin LH, Fleming ID, (1997) TNM classification of malignant tumors, fifth edition. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80: 1803-1804.
19. White JS, Weissfeld JL, Ragin CC, Rossie KM, Martin CL, et al. (2007) The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines. Oral Oncol 43: 701-712.
20. Kumar A, Becker LA, Depinet TW, Haren JM, Kurtz CL, et al. (1998) Molecular characterization and delineation of subtle deletions in de novo "balanced" chromosomal rearrangements. Hum Genet 103: 173-178.
21. MacGrogan D, Levy A, Bostwick D, Wagner M, Wells D, et al. (1994) Loss of chromosome arm 8p loci in prostate cancer: mapping by quantitative allelic imbalance. Genes Chromosomes Cancer 10: 151-159.
22. Chakraborty S, Mohiyuddin SM, Gopinath KS, Kumar A, (2008) Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma. BMC Cancer 8: 163.
23. Liu DW, Chen ST, Liu HP, (2005) Choice of endogenous control for gene expression in non small cell lung cancer. Eur Respir J 26: 1002-1008.
24. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
25. Beder LB, Gunduz M, Ouchida M, Gunduz E, Sakai A, et al. (2006) Identification of a candidate tumor suppressor gene RHOBTB1 located at a novel allelic loss region 10q21 in head and neck cancer. J Cancer Res Clin Oncol 132: 19-27.
26. Simmons ML, Lamborn KR, Takahashi M, Chen P, Israel MA, et al. (2001) Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res 61: 1122-1128.
27. Bajaj V, Singhmar P, Kumar A, (2008) Promoter characterization and regulation of expression of an imprinted gene SLC22A18AS. Gene 424: 40-47.
28. Baumann Kubetzko FB, Di Paolo C, Maag C, Meier R, Schafer BW, et al. (2004) The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line. Carcinogenesis 25: 1839-1846.
29. Tsai WC, Tsai ST, Jin YT, Wu LW, (2006) Cyclooxygenase-2 is involved in S100A2-mediated tumor suppression in squamous cell carcinoma. Mol Cancer Res 4: 539-547.
30. Wang W, Malcolm BA, (1999) Two-stage PCR protocol allowing introduction of multiple mutations, deletions and insertions using QuikChange Site-Directed Mutagenesis. Biotechniques 26: 680-682.
31. Sharbati-Tehrani S, Kutz-Lohroff B, Bergbauer R, Scholven J, Einspanier R, (2008) miR-Q: a novel quantitative RT-PCR approach for the expression profiling of small RNA molecules such as miRNAs in a complex sample. BMC Mol Biol 9: 34.
32. Pan S, Dong Q, Sun LS, Li TJ, (2010) Mechanisms of inactivation of PTCH1 gene in nevoid basal cell carcinoma syndrome: modification of the two-hit hypothesis. Clin Cancer Res 16: 442-450.
33. Trimborn M, Richter R, Sternberg N, Gavvovidis I, Schindler D, et al. (2005) The first missense alteration in the MCPH1 gene causes autosomal recessive microcephaly with an extremely mild cellular and clinical phenotype. Hum Mutat 26: 496.
34. Darvish H, Esmaeeli-Nieh S, Monajemi GB, Mohseni M, Ghasemi-Firouzabadi S, et al. (2010) A clinical and molecular genetic study of 112 Iranian families with primary microcephaly. J Med Genet 47: 823-828.
35. Farooq M, Baig S, Tommerup N, Kjar KW, (2010) Craniosyntosis-microcephaly with chromosomal breakage and other abnormalities is caused by a truncating MCPH1 mutation and is allelic to premature chromosomal condensation syndrome and primary autosomal recessive microcephaly type 1. Am J Med Genet A 152A: 495-497.
36. Hussain MS, Bakhtiar SM, Farooq M, Anjum I, Janzen E, et al. (2012) Genetic heterogeneity in Pakistani microcephaly families. Clin Genet 6: 9999.
37. Ghani-Kakhki M, Robinson PN, Morlot S, Mitter D, Trimborn M, et al. (2012) Two missense mutations in the primary autosomal recessive microcephaly gene MCPH1 disrupt the function of the highly conserved N-terminal BRCT domain of microcephalin. Mol Syndromol 3: 6-13.
38. Esteller M, (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21: 5427-5440.
39. Michor F, Polyak K, (2010) The origins and implications of intra-tumor heterogeneity. Cancer Prev Res 3: 1361-1364.
40. Zemliakova VV, Zhevlova AI, Strel'nikov VV, Liubchenko LN, Vishnevskaia Ia V, et al. (2003) Abnormal methylation of several tumor suppressor genes in sporadic breast cancer. Mol Biol 37: 696-703.
41. Shi L, Su B, (2012) Identification and functional characterization of a primate-specific E2F1 binding motif regulating MCPH1 expression. FEBS J 279: 491-503.
42. Hague A, Eveson JW, MacFarlane M, Huntley S, Janghra N, et al. (2004) Caspase-3 expression is reduced, in the absence of cleavage, in terminally differentiated normal oral epithelium but is increased in oral squamous cell carcinomas and correlates with tumour stage. J Pathol 204: 175-182.
43. Andressakis D, Lazaris AC, Tsiambas E, Kavantzas N, Rapidis A, et al. (2008) Evaluation of caspase-3 and caspase-8 deregulation in tongue squamous cell carcinoma, based on immunohistochemistry and computerised image analysis. J Laryngol Otol 122: 1213-1218.
44. Jiang L, Zeng X, Wang Z, Chen Q, (2009) Cell line cross-contamination: KB is not an oral squamous cell carcinoma cell line. Eur J Oral Sci 117: 90-91.
45. Saetrom P, Heale BS, Snove O, Aagaard L, Alluin J, et al. (2007) Distance constraints between microRNA target sites dictate efficacy and cooperativity. Nucleic Acids Res 35: 2333-2342.
46. Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, et al. (2010) Comprehensive microRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 16: 1129-1139.
47. Ma Y, Yu S, Zhao W, Lu Z, Chen J, (2010) miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Lett 298: 150-158.
48. Fukasawa K, (2005) Centrosome amplification, chromosome instability and cancer development. Cancer Lett 230: 6-19.
49. Kumar A, Girimaji SC, Duvvari MR, Blanton SH, (2009) Mutations in STIL, encoding a pericentriolar and centrosomal protein, cause primary microcephaly. Am J Hum Genet 84: 286-290.
50. Kaindl AM, Passemard S, Kumar P, Kraemer N, Issa L, et al. (2010) Many roads lead to primary autosomal recessive microcephaly. Prog Neurobiol 90: 363-383.
51. Bhat V, Girimaji SC, Mohan G, Arvinda HR, Singhmar P, et al. (2011) Mutations in WDR62, encoding a centrosomal and nuclear protein, in Indian primary microcephaly families with cortical malformations. Clin Genet 80: 532-540.
52. Hussain MS, Baig SM, Neumann S, Nurnberg G, Farooq M, et al. (2012) A truncating mutation of CEP135 causes primary microcephaly and disturbed centrosomal function. Am J Hum Genet 90: 871-878.
53. Kalay E, Yigit G, Aslan Y, Brown KE, Pohl E, et al. (2011) CEP152 is a genome maintenance protein disrupted in Seckel syndrome. Nat Genet 43: 23-26.
54. Bikeye SN, Colin C, Marie Y, Vampouille R, Ravassard P, et al. (2010) ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target. Cancer Cell Int 10: 1.
55. Xi S, Grandis JR, (2003) Gene therapy for the treatment of oral squamous cell carcinoma. J Dent Res 82: 11-16.